Skip to Content

a 135 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint a 135 is Blue / Yellow, Capsule-shape and has been identified as Fenofibric acid delayed-release 135 mg. It is supplied by Zydus Pharmaceuticals.

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for a 135

Fenofibric acid delayed-release

a 135
135 mg
Blue / Yellow
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Zydus Pharmaceuticals
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.